“biotech” Archives

in
Entry Author Date Location
Nike’s Jim Scholefield Jumps to Merck to Lead Digital Strategy 10/17/18 New York
Ziopharm Chief Medical Officer Francois Lebel to Step Down 10/17/18 Boston
Report: Express Scripts Shuts Out Teva Migraine Drug, Prefers Rivals 10/17/18 National
Spinraza Inventors Take Home $3M Breakthrough Prize in Life Sciences 10/17/18 National
ATyr Pharma Chief Scientific Officer, David King, to Resign 10/17/18 San Diego
Eli Lilly’s David Bleakman Joins Redpin as Chief Scientific Officer 10/16/18 New York
Rheos Medicines Names Gad Soffer Chief Operating Officer 10/16/18 Boston
Stratatech Gets $26M More to Develop Skin Tissue for Treating Burns 10/16/18 Wisconsin
Warp Drive’s Odyssey Ends with a Buyout—By Revolution, Not Sanofi 10/16/18 San Francisco
Former Amgen Exec Sersch Joins Mustang Bio as Chief Medical Officer 10/15/18 New York
Rhythm Pharma Appoints Murray Stewart Chief Medical Officer 10/15/18 Boston
Roche and SQZ Biotech Expand R&D Pact in Pursuit of New Cancer Drugs 10/15/18 Boston
Ansun BioPharma Adds Stanley Lewis to C-Suite 10/12/18 San Diego
Adynxx Agrees to Merger with Alliqua to Gain Public Stock Listing 10/12/18 San Francisco
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More 10/12/18 National
BIO Has Big Diversity Goals. Does It Have the Means to Reach Them? 10/11/18 National
Xconomy Awards 2018 Gala Honors the Best of Boston Life Science: Slideshow 10/11/18 Boston
Allogene’s IPO Raises $288M for Tests of “Off-the-Shelf” Cell Therapy 10/11/18 San Francisco
Swabbing DNA on Phones Reveals Mysteries of Microbial World Around Us 10/10/18 Wisconsin
BioCrossroads Unveils New $9M Seed Fund for Biotech, Agbio Startups 10/10/18 Indiana
CRISPR Therapeutics, Vertex Get FDA Green Light for Sickle Cell Test 10/10/18 Boston
With Vernalis Buy, Ligand Adds to Portfolio, Establishes U.K. Presence 10/10/18 San Diego
ContraVir Names Robert Foster Acting CEO in Executive Shuffle 10/10/18 New York
Harpoon Therapeutics Appoints Natalie Sacks Chief Medical Officer 10/10/18 San Francisco
In New York, Gotham Starts Up With $54M for RNA-Modifying Drugs 10/10/18 New York
Eyeing NASH, Glympse Raises $22M to Test Disease Detection Nanotech 10/09/18 Boston
Click Therapeutics Adds Randall Kaye, Austin Speier to C-Suite 10/08/18 New York
NGM Biopharma Promotes Woodhouse to CEO, Trombley to President 10/08/18 San Francisco
Menlo’s Drug Fails Again in Clinical Trials, This Time for Chronic Cough 10/08/18 San Francisco
New VARI Initiative Aims to Understand How Metabolism Drives Disease 10/08/18 Detroit Ann Arbor
Page 1 of 283 next page »